Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Reagan

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Oncotarget|June 19, 2023
The hope for targeting fatty acid binding proteins in multiple myelomaHeather Fairfield, Michaela R Reagan
Cancer Discovery|April 1, 2026
Fiber: A New Myeloma Prevention Approach with Abundant Positive EffectsHeather Fairfield, Michaela R Reagan
Frontiers in Endocrinology|May 17, 2018
Soluble and Cell-Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple MyelomaMariah L Farrell, Michaela R Reagan
Stem Cells (Dayton, Ohio)|May 11, 2011
Concise review: Mesenchymal stem cell tumor-homing: detection methods in disease model systemsMichaela R Reagan, David L Kaplan
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1976
The biology of growth hormoneJ L Kostyo, C R Reagan
The American Journal of Physiology|June 1, 1994
Ten years of basic medical physiology in the Mercer problem-based curriculumC R Reagan, R P Menninger
The Annals of Pharmacotherapy|February 1, 1996
Association of a Tourette-like syndrome with ofloxacinR J Thomas, D R Reagan
Nature Reviews. Rheumatology|November 27, 2015
Navigating the bone marrow niche: translational insights and cancer-driven dysfunctionMichaela R Reagan, Clifford J Rosen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effectsMichaela R Reagan, Irene M Ghobrial
Frontiers in Endocrinology|January 24, 2019
Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple MyelomaDanielle Harmer, Carolyne Falank, Michaela R Reagan
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Oncotarget|June 19, 2023
The hope for targeting fatty acid binding proteins in multiple myelomaHeather Fairfield, Michaela R Reagan
Cancer Discovery|April 1, 2026
Fiber: A New Myeloma Prevention Approach with Abundant Positive EffectsHeather Fairfield, Michaela R Reagan
Frontiers in Endocrinology|May 17, 2018
Soluble and Cell-Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple MyelomaMariah L Farrell, Michaela R Reagan
Stem Cells (Dayton, Ohio)|May 11, 2011
Concise review: Mesenchymal stem cell tumor-homing: detection methods in disease model systemsMichaela R Reagan, David L Kaplan
Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology|January 1, 1976
The biology of growth hormoneJ L Kostyo, C R Reagan
The American Journal of Physiology|June 1, 1994
Ten years of basic medical physiology in the Mercer problem-based curriculumC R Reagan, R P Menninger
The Annals of Pharmacotherapy|February 1, 1996
Association of a Tourette-like syndrome with ofloxacinR J Thomas, D R Reagan
Nature Reviews. Rheumatology|November 27, 2015
Navigating the bone marrow niche: translational insights and cancer-driven dysfunctionMichaela R Reagan, Clifford J Rosen
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2011
Multiple myeloma mesenchymal stem cells: characterization, origin, and tumor-promoting effectsMichaela R Reagan, Irene M Ghobrial
Frontiers in Endocrinology|January 24, 2019
Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple MyelomaDanielle Harmer, Carolyne Falank, Michaela R Reagan
Pageof 13